The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Mutations in the NF-κB signaling pathway: implications for human disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Hayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842
Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,829
Ubiquitin signalling in the NF-κB pathway
Chen, Z. J. (2005) · Nature Cell Biology · doi:10.1038/ncb0805-758 · Cited by 1,184
Davis, R. E., Brown, K. D., Siebenlist, U., & Staudt, L. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.12.1861 · Cited by 1,051
The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination
Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israël, A., Wallach, D., & Courtois, G. (2003) · Nature · doi:10.1038/nature01802 · Cited by 1,016
Self-citationCYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members
Trompouki, E., Hatzivassiliou, E., Tsichritzis, T., Farmer, H., Ashworth, A., & Mosialos, G. (2003) · Nature · doi:10.1038/nature01803 · Cited by 961
Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB
Brummelkamp, T. R., Nijman, S. M. B., Dirac, A. M. G., & Bernards, R. (2003) · Nature · doi:10.1038/nature01811 · Cited by 952
Signalling pathways and molecular interactions of NOD1 and NOD2
Strober, W., Murray, P. J., Kitani, A., & Watanabe, T. (2006) · Nature Reviews Immunology · doi:10.1038/nri1747 · Cited by 856
NF-κB-Inducing Kinase Regulates the Processing of NF-κB2 p100
Xiao, G., Harhaj, E. W., & Sun, S.-C. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00187-3 · Cited by 834
X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-κB signaling
Döffinger, R., Smahi, A., Bessia, C., Geissmann, F., Feinberg, J., Durandy, A., Bodemer, C., Kenwrick, S., Dupuis-Girod, S., Blanche, S., et al. (2001) · Nature Genetics · doi:10.1038/85837 · Cited by 828
Self-citationUbiquitin and ubiquitin-like proteins as multifunctional signals
Welchman, R. L., Gordon, C., & Mayer, R. J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1700 · Cited by 828
Pyogenic Bacterial Infections in Humans with IRAK-4 Deficiency
Picard, C., Puel, A., Bonnet, M., Ku, C.-L., Bustamante, J., Yang, K., Soudais, C., Dupuis, S., Feinberg, J., Fieschi, C., et al. (2003) · Science · doi:10.1126/science.1081902 · Cited by 826
Bargou, R. C., Emmerich, F., Krappmann, D., Bommert, K., Mapara, M. Y., Arnold, W., Royer, H. D., Grinstein, E., Greiner, A., Scheidereit, C., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119849 · Cited by 761
Genomic rearrangement in NEMO impairs NF-κB activation and is a cause of incontinentia pigmenti
The International Incontinentia Pigmenti (IP) Consortium (2000) · Nature · doi:10.1038/35013114 · Cited by 750
Identification of the familial cylindromatosis tumour-suppressor gene
Bignell, G. R., Warren, W., Seal, S., Takahashi, M., Rapley, E., Barfoot, R., Green, H., Brown, C., Biggs, P. J., Lakhani, S. R., et al. (2000) · Nature Genetics · doi:10.1038/76006 · Cited by 666
Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema
Karkkainen, M. J., Ferrell, R. E., Lawrence, E. C., Kimak, M. A., Levinson, K. L., McTigue, M. A., Alitalo, K., & Finegold, D. N. (2000) · Nature Genetics · doi:10.1038/75997 · Cited by 650
Dawson, S. J., Wiman, B., Hamsten, A., Green, F., Humphries, S., & Henney, A. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82047-6 · Cited by 569
Zonana, J., Elder, M. E., Schneider, L. C., Orlow, S. J., Moss, C., Golabi, M., Shapira, S. K., Farndon, P. A., Wara, D. W., Emmal, S. A., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/316914 · Cited by 521
Bours, V (1993) · Cell · doi:10.1016/0092-8674(93)90401-b · Cited by 495
Cyld Inhibits Tumor Cell Proliferation by Blocking Bcl-3-Dependent NF-κB Signaling
Massoumi, R., Chmielarska, K., Hennecke, K., Pfeifer, A., & Fässler, R. (2006) · Cell · doi:10.1016/j.cell.2006.03.041 · Cited by 476
TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2
Pasparakis, M., Courtois, G., Hafner, M., Schmidt-Supprian, M., Nenci, A., Toksoy, A., Krampert, M., Goebeler, M., Gillitzer, R., Israel, A., et al. (2002) · Nature · doi:10.1038/nature00820 · Cited by 470
Self-citationOhno, H. (1990) · Cell · doi:10.1016/0092-8674(90)90347-h · Cited by 456
Cogswell, P. C., Guttridge, D. C., Funkhouser, W. K., & Baldwin, A. S. (2000) · Oncogene · doi:10.1038/sj.onc.1203412 · Cited by 452
NEMO/IKKγ-Deficient Mice Model Incontinentia Pigmenti
Schmidt-Supprian, M., Bloch, W., Courtois, G., Addicks, K., Israël, A., Rajewsky, K., & Pasparakis, M. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80263-4 · Cited by 437
Self-citationDifferential modulation of endotoxin responsiveness by human caspase-12 polymorphisms
Saleh, M., Vaillancourt, J. P., Graham, R. K., Huyck, M., Srinivasula, S. M., Alnemri, E. S., Steinberg, M. H., Nolan, V., Baldwin, C. T., Hotchkiss, R. S., et al. (2004) · Nature · doi:10.1038/nature02451 · Cited by 422
New genes involved in cancer identified by retroviral tagging
Suzuki, T., Shen, H., Akagi, K., Morse, H. C., Malley, J. D., Naiman, D. Q., Jenkins, N. A., & Copeland, N. G. (2002) · Nature Genetics · doi:10.1038/ng949 · Cited by 420
Lymphoid Malignancies: the dark side of B-cell differentiation
Shaffer, A. L., Rosenwald, A., & Staudt, L. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri953 · Cited by 419
Fujita, T., Nolan, G. P., Liou, H. C., Scott, M. L., & Baltimore, D. (1993) · Genes & Development · doi:10.1101/gad.7.7b.1354 · Cited by 409
Makris, C., Godfrey, V. L., Krähn-Senftleben, G., Takahashi, T., Roberts, J. L., Schwarz, T., Feng, L., Johnson, R. S., & Karin, M. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80262-2 · Cited by 395
Jain, A., Ma, C. A., Liu, S., Brown, M., Cohen, J., & Strober, W. (2001) · Nature Immunology · doi:10.1038/85277 · Cited by 392
Neri, A., Chang, C.-C., Lombardi, L., Salina, M., Corradini, P., Maiolo, A. T., Chaganti, R. S. K., & Dalla-Favera, R. (1991) · Cell · doi:10.1016/0092-8674(91)90285-7 · Cited by 390
Courtois, G., Smahi, A., Reichenbach, J., Döffinger, R., Cancrini, C., Bonnet, M., Puel, A., Chable-Bessia, C., Yamaoka, S., Feinberg, J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18714 · Cited by 376
Self-citationCATERPILLERs, pyrin and hereditary immunological disorders
Ting, J. P.-Y., Kastner, D. L., & Hoffman, H. M. (2006) · Nature Reviews Immunology · doi:10.1038/nri1788 · Cited by 342
Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα
Cabannes, E., Khan, G., Aillet, F., Jarrett, R. F., & Hay, R. T. (1999) · Oncogene · doi:10.1038/sj.onc.1202893 · Cited by 334
Chromosomal and Gene Amplification in Diffuse Large B-Cell Lymphoma
Rao, P. H., Houldsworth, J., Dyomina, K., Parsa, N. Z., Cigudosa, J. C., Louie, D. C., Popplewell, L., Offit, K., Jhanwar, S. C., & Chaganti, R. S. K. (1998) · Blood · doi:10.1182/blood.v92.1.234.413k22_234_240 · Cited by 331
Incontinentia pigmenti: A review and update on the molecular basis of pathophysiology
Berlin, A. (2002) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(02)00046-4 · Cited by 313
The Bcl-3 oncoprotein acts as a bridging factor between NF-κB/Rel and nuclear co-regulators
Dechend, R., Hirano, F., Lehmann, K., Heissmeyer, V., Ansieau, S., Wulczyn, F. G., Scheidereit, C., & Leutz, A. (1999) · Oncogene · doi:10.1038/sj.onc.1202717 · Cited by 312
High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells
Bargou, R., Leng, C., Krappmann, D., Emmerich, F., Mapara, M., Bommert, K., Royer, H., Scheidereit, C., & Dorken, B. (1996) · Blood · doi:10.1182/blood.v87.10.4340.bloodjournal87104340 · Cited by 309
van Heel, D. A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.11.1281 · Cited by 291
Clonal Deleterious Mutations in the Iκbα Gene in the Malignant Cells in Hodgkin's Lymphoma
Jungnickel, B., Staratschek-Jox, A., Bräuninger, A., Spieker, T., Wolf, J., Diehl, V., Hansmann, M.-L., Rajewsky, K., & Küppers, R. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.395 · Cited by 283
Filipe-Santos, O., Bustamante, J., Haverkamp, M. H., Vinolo, E., Ku, C.-L., Puel, A., Frucht, D. M., Christel, K., von Bernuth, H., Jouanguy, E., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060085 · Cited by 282
Combined Functional Genomic Maps of the C. elegans DNA Damage Response
Boulton, S. J., Gartner, A., Reboul, J., Vaglio, P., Dyson, N., Hill, D. E., & Vidal, M. (2002) · Science · doi:10.1126/science.1065986 · Cited by 280
Molecular mechanisms of constitutive NF-κB/Rel activation in Hodgkin/Reed-Sternberg cells
Krappmann, D., Emmerich, F., Kordes, U., Scharschmidt, E., Dörken, B., & Scheidereit, C. (1999) · Oncogene · doi:10.1038/sj.onc.1202351 · Cited by 271
Hinz, M., Löser, P., Mathas, S., Krappmann, D., Dörken, B., & Scheidereit, C. (2001) · Blood · doi:10.1182/blood.v97.9.2798 · Cited by 261
Medvedev, A. E., Lentschat, A., Kuhns, D. B., Blanco, J. C. G., Salkowski, C., Zhang, S., Arditi, M., Gallin, J. I., & Vogel, S. N. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030701 · Cited by 261
Emmerich, F., Meiser, M., Hummel, M., Demel, G., Foss, H.-D., Jundt, F., Mathas, S., Krappmann, D., Scheidereit, C., Stein, H., et al. (1999) · Blood · doi:10.1182/blood.v94.9.3129 · Cited by 261
Feuerhake, F. (2005) · Blood · doi:10.1182/blood-2004-12-4901 · Cited by 244
Martinez-Climent, J. A., Alizadeh, A. A., Segraves, R., Blesa, D., Rubio-Moscardo, F., Albertson, D. G., Garcia-Conde, J., Dyer, M. J. S., Levy, R., Pinkel, D., et al. (2003) · Blood · doi:10.1182/blood-2002-07-2119 · Cited by 240
Joos, S., Menz, C. K., Wrobel, G., Siebert, R., Gesk, S., Ohl, S., Mechtersheimer, G., Trümper, L., Möller, P., Lichter, P., et al. (2002) · Blood · doi:10.1182/blood.v99.4.1381 · Cited by 238
Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice
Lund, A. H., Turner, G., Trubetskoy, A., Verhoeven, E., Wientjens, E., Hulsman, D., Russell, R., DePinho, R. A., Lenz, J., & van Lohuizen, M. (2002) · Nature Genetics · doi:10.1038/ng956 · Cited by 230
Association between tuberculosis and a polymorphic NFκB binding site in the interferon γ gene
Rossouw, M., Nel, H. J., Cooke, G. S., van Helden, P. D., & Hoal, E. G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13491-5 · Cited by 224
Immunological adjuvants promote activated T cell survival via induction of Bcl-3
Mitchell, T. C., Hildeman, D., Kedl, R. M., Teague, T. K., Schaefer, B. C., White, J., Zhu, Y., Kappler, J., & Marrack, P. (2001) · Nature Immunology · doi:10.1038/87692 · Cited by 221
IRAK-4 as the central TIR signaling mediator in innate immunity
Suzuki, N., Suzuki, S., & Yeh, W.-C. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02298-6 · Cited by 220
Ectodysplasin signaling in development.
Mikkola, M. L., & Thesleff, I. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00020-0 · Cited by 217
Tagawa, H. (2005) · Blood · doi:10.1182/blood-2005-02-0542 · Cited by 217
REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma
Houldsworth, J., Mathew, S., Rao, P., Dyomina, K., Louie, D., Parsa, N., Offit, K., & Chaganti, R. (1996) · Blood · doi:10.1182/blood.v87.1.25.25 · Cited by 211
Functional Consequences of a Polymorphism Affecting NF-κB p50-p50 Binding to the TNF Promoter Region
Udalova, I. A., Richardson, A., Denys, A., Smith, C., Ackerman, H., Foxwell, B., & Kwiatkowski, D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.24.9113-9119.2000 · Cited by 207
Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel
Gilmore, T. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203222 · Cited by 200
Self-citationBours, V., Dejardin, E., Goujon-Letawe, F., Merville, M.-P., & Castronovo, V. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90448-0 · Cited by 185
The Putative Oncoprotein Bcl-3 Induces Cyclin D1 To Stimulate G1 Transition
Westerheide, S. D., Mayo, M. W., Anest, V., Hanson, J. L., & Baldwin, A. S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.24.8428-8436.2001 · Cited by 182
Ishikawa, H., Carrasco, D., Claudio, E., Ryseck, R.-P., & Bravo, R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.999 · Cited by 176
Fusco, F., Bardaro, T., Fimiani, G., Mercadante, V., Miano, M. G., Falco, G., Israël, A., Gilles, C., D'Urso, M., & Ursini, M. V. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh192 · Cited by 175
Mining for regulatory programs in the cancer transcriptome
Rhodes, D. R., Kalyana-Sundaram, S., Mahavisno, V., Barrette, T. R., Ghosh, D., & Chinnaiyan, A. M. (2005) · Nature Genetics · doi:10.1038/ng1578 · Cited by 169
Sequence Variants of Toll-Like Receptor 4 and Susceptibility to Prostate Cancer
Chen, Y.-C., Giovannucci, E., Lazarus, R., Kraft, P., Ketkar, S., & Hunter, D. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2078 · Cited by 167
Negative Regulation of JNK Signaling by the Tumor Suppressor CYLD
Reiley, W. W., Zhang, M., & Sun, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411049200 · Cited by 163
Ruíz-Ballesteros, E., Mollejo, M., Rodríguez, A., Camacho, F. I., Algara, P., Martínez, N., Pollán, M., Sánchez‐Aguilera, A., Menárguez, J., Campo, E., et al. (2005) · Blood · doi:10.1182/blood-2004-10-3898 · Cited by 161
Arcaroli, J. J., Silva, E., Maloney, J. P., He, Q., Svetkauskaite, D., Murphy, J. R., & Abraham, E. H. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200603-341oc · Cited by 155
GSK3-Mediated BCL-3 Phosphorylation Modulates Its Degradation and Its Oncogenicity
Viatour, P., Dejardin, E., Warnier, M., Lair, F., Claudio, E., Bureau, F., Marine, J., Merville, M., Maurer, U., Green, D. R., et al. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.09.004 · Cited by 154
Inactivating I kappa B epsilon mutations in Hodgkin/Reed–Sternberg cells
Emmerich, F., Theurich, S., Hummel, M., Haefker, A., Vry, M. S., Döhner, K., Bommert, K., Stein, H., & Dörken, B. (2003) · The Journal of Pathology · doi:10.1002/path.1454 · Cited by 152
Aradhya, S., Courtois, G., Rajkovic, A., Lewis, R. A., Levy, M. L., Israël, A., & Nelson, D. L. (2001) · The American Journal of Human Genetics · doi:10.1086/318806 · Cited by 148
Self-citationThe c-Rel transcription factor and B-cell proliferation: a deal with the devil
Gilmore, T. D., Kalaitzidis, D., Liang, M., & Starczynowski, D. T. (2004) · Oncogene · doi:10.1038/sj.onc.1207410 · Cited by 147
Self-citationThe Same IκBα Mutation in Two Related Individuals Leads to Completely Different Clinical Syndromes
Janssen, R., van Wengen, A., Hoeve, M. A., ten Dam, M., van der Burg, M., van Dongen, J. J. M., van de Vosse, E., van Tol, M., Bredius, R. G. M., Ottenhoff, T. H. M., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040773 · Cited by 137
Regamey, A., Hohl, D., Liu, J. W., Roger, T., Kogerman, P., Toftgård, R., & Huber, M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031187 · Cited by 130
Bentz, M., Werner, C., Döhner, H., Joos, S., Barth, T., Siebert, R., Schroder, M., Stilgenbauer, S., Fischer, K., Mӧller, P., et al. (1996) · Blood · doi:10.1182/blood.v88.4.1437.bloodjournal8841437 · Cited by 128
Defective IκBα in Hodgkin cell lines with constitutively active NF-κB
Wood, K. M., Roff, M. A., & Hay, R. T. (1998) · Oncogene · doi:10.1038/sj.onc.1201735 · Cited by 127
Nenci, A., Huth, M., Funteh, A., Schmidt‐Supprian, M., Bloch, W., METZGER, D., Chambon, P., Rajewsky, K., Krieg, T. M., Haase, I., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi470 · Cited by 125
Orange, J. S., Levy, O., Brodeur, S. R., Krzewski, K., Roy, R. M., Niemela, J. E., Fleisher, T. A., Bonilla, F. A., & Geha, R. S. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.06.052 · Cited by 122
Puel, A., Reichenbach, J., Bustamante, J. C., Ku, C., Feinberg, J. M., Döffinger, R., Bonnet, M., Filipe‐Santos, O., de Beaucoudrey, L., Durandy, A., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/501532 · Cited by 120
Pham, L. V., Tamayo, A. T., Yoshimura, L. C., Lin-Lee, Y.-C., & Ford, R. J. (2005) · Blood · doi:10.1182/blood-2005-03-1167 · Cited by 119
Hidaka, F., Matsuo, S., Muta, T., Takeshige, K., Mizukami, T., & Nunoi, H. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.01.005 · Cited by 109
The CAP-Gly Domain of CYLD Associates with the Proline-Rich Sequence in NEMO/IKKγ
Saito, K., Kigawa, T., Koshiba, S., Sato, K. Z., Matsuo, Y., Sakamoto, A., Takagi, T., Shirouzu, M., Yabuki, T., Nunokawa, E., et al. (2004) · Structure · doi:10.1016/j.str.2004.07.012 · Cited by 106
Large B‐cell lymphoma with Hodgkin's features
García, J. F., Mollejo, M., Fraga, M., Forteza, J., Soriano, J. A. M., Pérez‐Guillermo, M., Pérez-Seoane, C., Rivera, T., Ortega, P., & Piris, M. A. (2005) · Histopathology · doi:10.1111/j.1365-2559.2005.02175.x · Cited by 105
Weßendorf, S., Schwäenen, C., Kohlhammer, H., Kienle, D., Wrobel, G., Barth, T. F. E., Neßling, M., Möller, P., Döhner, H., Lichter, P., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206297 · Cited by 105
Migliazza, A., Lombardi, L. T., Rocchi, M., Trecca, D., Chang, C. M., Antonacci, R., Fracchiolla, N., Ciana, P., Maiolo, A. T., & Neri, A. (1994) · Blood · doi:10.1182/blood.v84.11.3850.bloodjournal84113850 · Cited by 104
Abnormalities in the NF‐κB family and related proteins in endometrial carcinoma
Pallarés, J., Martínez‐Guitarte, J., Dolcet, X., Llobet‐Navàs, D., Rué, M., Palacios, J., Prat, J., & Matías‐Guiu, X. (2004) · The Journal of Pathology · doi:10.1002/path.1666 · Cited by 104
Orange, J. S., Levy, O., & Geha, R. S. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00221.x · Cited by 103
NF-κB-related genetic diseases
Courtois, G., & Smahi, A. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401841 · Cited by 100
Self-citationBeà, S., Colomo, L., López‐Guillermo, A., Salaverría, I., Puig, X., Pinyol, M., Rives, S., Montserrat, E., & Campo, E. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.025 · Cited by 99
Houldsworth, J., Olshen, A. B., Cattoretti, G., Donnelly, G. B., Teruya‐Feldstein, J., Qin, J., Palanisamy, N., Shen, Y., Dyomina, K., Petlakh, M., et al. (2003) · Blood · doi:10.1182/blood-2003-04-1359 · Cited by 98
Chen, W., Houldsworth, J., Olshen, A. B., Nanjangud, G. J., Chaganti, S. R., Venkatraman, E. S., Halaas, J. L., Teruya‐Feldstein, J., Zelenetz, A. D., & Chaganti, R. S. K. (2005) · Blood · doi:10.1182/blood-2005-07-2950 · Cited by 93
Genetic alterations in primary cutaneous CD30+ anaplastic large cell lymphoma
Mao, X., Orchard, G. E., Lillington, D. M., Russell‐Jones, R., Young, B. D., & Whittaker, S. J. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10184 · Cited by 91
Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel
Gilmore, T. D., Cormier, C., Jean-Jacques, J., & Gapuzan, M.-E. R. (2001) · Oncogene · doi:10.1038/sj.onc.1204898 · Cited by 88
Self-citationSchedel, M., Carr, D., Klopp, N., Woitsch, B., Illig, T., Stachel, D., Schmid, I., Fritzsch, C., Weiland, S. K., von Mutius, E., et al. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.07.048 · Cited by 84
Goff, L. K., Neat, M. J., Crawley, C. R., Jones, L., Jones, E., Lister, T. A., & Gupta, R. K. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02352.x · Cited by 82
Genetics of Paget's disease of bone
Daroszewska, A., & Ralston, S. H. (2005) · Clinical Science · doi:10.1042/cs20050053 · Cited by 82
Multiple Familial Trichoepithelioma Caused by Mutations in the Cylindromatosis Tumor Suppressor Gene
Salhi, A., Bornholdt, D., Oeffner, F., Malik, S., Heid, E., Happle, R., & Grzeschik, K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0307 · Cited by 75
Bcl3, an IκB Protein, Stimulates Activating Protein-1 Transactivation and Cellular Proliferation
Na, S.-Y., Choi, J. E., Kim, H.-J., Jhun, B. H., Lee, Y., & Lee, J. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.40.28491 · Cited by 67
NF-κB2 p100 is a pro-apoptotic protein with anti-oncogenic function
Wang, Y., Cui, H., Schroering, A. G., Ding, J., Lane, W. S., McGill, G. G., Fisher, D. E., & Ding, H. (2002) · Nature Cell Biology · doi:10.1038/ncb872 · Cited by 63
Kang, S., Kim, Y. B., Kim, M., Yoon, K., Kim, J., Park, N. H., Song, Y. S., Kang, D., Yoo, K.-Y., Kang, S. B., et al. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.06.053 · Cited by 58
Kalaitzidis, D., Davis, R. E., Rosenwald, A., Staudt, L. M., & Gilmore, T. D. (2002) · Oncogene · doi:10.1038/sj.onc.1206033 · Cited by 57
Self-citationCharacterization of target genes at the 2p15–16 amplicon in diffuse large B‐cell lymphoma
Fukuhara, N., Tagawa, H., Kameoka, Y., Kasugai, Y., Karnan, S., Kameoka, J., Sasaki, T., Morishima, Y., Nakamura, S., & Seto, M. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00209.x · Cited by 50
Levine, A., Karban, A. S., Eliakim, R., Shaoul, R. R., Reif, S. S., Pacht, A., Wardi, J., Yakir, B., & Leshinsky‐Silver, E. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41126.x · Cited by 46
Neat, M. J., Foot, N. J., Jenner, M., Goff, L. K., Ashcroft, K. J., Burford, D. C., Dunham, A., Norton, A. J., Lister, T. A., & Fitzgibbon, J. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.1187 · Cited by 43
Comparative genomic hybridization detects genomic abnormalities in 80% of follicular lymphomas
Avet‐Loiseau, H., Vigier, M., MOREAU, A., Mellerin, M., Gaillard, F., Harousseau, J., Bataille, R., & Milpied, N. J. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.d01-2140.x · Cited by 43
Mao, X., Onadim, Z., Price, E. A., Child, F. J., Lillington, D. M., Russell‐Jones, R., Young, B. D., & Whittaker, S. J. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12406.x · Cited by 42
Ciana, P., Neri, A., Cappellini, C., Cavallo, F., Pomati, M., Chang, C., Maiolo, A. T., & Lombardi, L. (1997) · Oncogene · doi:10.1038/sj.onc.1201015 · Cited by 40
Splenic small B-cell lymphoma with IGH/BCL3 translocation
Soma, L. A., Gollin, S. M., Remstein, E. D., Ketterling, R. P., Flynn, H. C., Rajasenan, K. K., & Swerdlow, S. H. (2006) · Human Pathology · doi:10.1016/j.humpath.2005.09.025 · Cited by 32
Starczynowski, D. T., Reynolds, J. G., & Gilmore, T. D. (2005) · Oncogene · doi:10.1038/sj.onc.1208902 · Cited by 27
Self-citationSchlette, E. J., Rassidakis, G. Z., Canöz, Ö., & Medeiros, L. J. (2005) · American Journal of Clinical Pathology · doi:10.1309/6q27-q3nd-gv8l-w1bu · Cited by 23
Transcriptional regulatory effects of lymphoma-associated NFKB2/lyt10 protooncogenes
Kim, K.-E., Gu, C., Thakur, S., Vieira, E., Lin, J., & Rabson, A. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203432 · Cited by 23
The −844C/T polymorphism in the Fas ligand promoter associates with Taiwanese SLE
Chen, J. Y., Wang, C. M., C, C., Chow, Y. H., & Luo, S. F. (2005) · Genes and Immunity · doi:10.1038/sj.gene.6364158 · Cited by 20
Saha, A., Bairwa, N., Ranjan, A., Gupta, V., & Bamezai, R. (2003) · European journal of immunogenetics · doi:10.1111/j.1365-2370.2003.00423.x · Cited by 14
Cited by
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,494
The complexity of NF-κB signaling in inflammation and cancer
Hoesel, B., & Schmid, J. A. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-86 · Cited by 3,165
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Mogensen, T. H. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00046-08 · Cited by 3,111
The NF- B Family of Transcription Factors and Its Regulation
Oeckinghaus, A., & Ghosh, S. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000034 · Cited by 2,842
Metadata
- Authors
- Courtois, G., & Gilmore, T. D.
- Venue
- Oncogene
- Published
- 2006-10-30
- Volume
- 25
- Issue
- 51
- Pages
- 6831-6843
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1966923590
- Cited by
- 525
- References
- 115
- FWCI
- 12.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.